Product Name | MF | CAS | Details |
---|
2-Amino-5-(trifluoromethoxy)phenyl thiocyanate | C8H5F3N2OS | 1391054-04-8 | Details |
2-(1-Methylcyclobutyl)acetic acid | C7H12O2 | 146723-08-2 | Details |
ATP5L2 antibody | Details |
N-Benzoyl- 5'- O- DMT- 2'- O-[( triisopropylsilyl oxy)methyl]-adenosine 3'- CE phosphoramidite | C57H74N7O9PSi | 220230-59-1 | Details |
Ethyl 4-(bromomethyl)-5,5-dimethyl-2-oxo-2,5-dihydrofuran-3-carboxylate | C10H13BrO4 | 90261-67-9 | Details |
SNAC11 antibody | Details |
BTF3L1 Blocking Peptide | Details |
4,4'-Dibromo-p-terphenyl | C18H12Br2 | 17788-94-2 | Details |
N,N-Diethyl-1-(2-methoxyphenyl)-2-sulfanyl-1H-1,3-benzodiazole-5-sulfonamide | C18H21N3O3S2 | 380431-56-1 | Details |
TP-434 2HCl | C27H32ClFN4O8 | 1334714-66-7 | Details |
2-Morpholin-4-yl-1,3-benzothiazol-6-amine | C11H13N3OS | 850021-27-1 | Details |
Rivabazumab | 1627519-84-9 | Details |
1α,4β,10β-Trihydroxyguaia-2,11(13)-dien-12,6α-olide | C15H20O5 | 221148-94-3 | Details |
6-(p-Tolyl)pyridin-2-amine | C12H12N2 | 154479-28-4 | Details |
NCR/Nkp46 protein | Details |
N1,N1-Bis(pyridin-2-ylmethyl)ethane-1,2-diamine | C14H18N4 | 189440-33-3 | Details |
Gomesin (AgGom) | Details |
3-Chloro-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propan-1-one | C11H11ClO3 | 111038-91-6 | Details |
6-Chloro-3-formyl-2-picoline | C7H6ClNO | 884495-36-7 | Details |
2,4,5-Trichlorothiazole | C3Cl3NS | 50844-30-9 | Details |
R-IMPP hydrochloride | C24H28ClN3O2 | 2173005-10-0 | Details |
N-(3-Amino-4-methylphenyl)-2,2-dimethylpropanamide | C12H18N2O | 946709-89-3 | Details |
1,2,3,4-Tetrahydro-[1,7]naphthyridine dihydrochloride | C8H12Cl2N2 | 1187933-44-3 | Details |
2'-O-tert-Butyldimethylsilyl-5'-O-DMT-adenosine | C37H45N5O6Si | 81794-13-0 | Details |
Potassium 2-(dimethylamino)-2-methylpent-4-enoate | 2243514-97-6 | Details |
Cephalomannine | C45H53NO14 | 71610-00-9 | Details |
Sikokianin A | C31H24O10 | 106293-99-6 | Details |
Penicillin V potassium salt | C16H17KN2O5S | 132-98-9 | Details |
Oxytetracycline anhydrous | C22H24N2O9 | 79-57-2 | Details |
Recombinant Human MCP-4 | Details |
9-Methylxanthine | C6H6N4O2 | 1198-33-0 | Details |
FEMA 4774 | C19H25N3O4 | 1359963-68-0 | Details |
1-(4-Fluorophenyl)pyrazole-4-boronic acid | C9H8BFN2O2 | 1072945-89-1 | Details |
5-Cyclopropylisoxazole-4-carboxylic acid | C7H7NO3 | 124845-04-1 | Details |
2-(4-Chlorobenzenesulfinyl)acetic acid | C8H7ClO3S | 3996-47-2 | Details |
(1R)-3-Methoxy-1-phenylpropan-1-amine hydrochloride | 2247088-21-5 | Details |
ApoA2 protein | Details |
trans-3-Indoleacrylic acid | C11H9NO2 | 29953-71-7 | Details |
(2E)-3-(1-Methyl-1H-indol-3-yl)prop-2-enoic acid | C12H11NO2 | 205884-12-4 | Details |
Muscimol hydrobromide | C4H6N2O2.BrH | 18174-72-6 | Details |
Ginsenoside Ra3 | C59H100O27 | 90985-77-6 | Details |
Oxytocin Receptor antibody | Details |
(S)-2-((tert-Butoxycarbonyl)amino)-2-(1-methylcyclopropyl)acetic acid | C11H19NO4 | 928758-14-9 | Details |
Fmoc-Ser(tBu)-Wang resin (100-200 mesh) | Details |
RASL10A Blocking Peptide | Details |
4,6-Dimethoxysalicylaldehyde | C9H10O4 | 708-76-9 | Details |
6-(Trifluoromethyl)pyridazine-3-carboxylic Acid | C6H3F3N2O2 | 1192155-05-7 | Details |
4,4,4-Trifluoro-3-oxobutanenitrile | C4H2F3NO | 110234-68-9 | Details |
2-(3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-yl)acetic acid | C6H8N2O3 | 845808-92-6 | Details |
Colchicine fluorescein | C41H34N2O10S | 66091-34-7 | Details |
6-Chloro-2,3-dihydro-1H-pyrrolo[3,2-c]pyridine | C7H7ClN2 | 23596-25-0 | Details |
AZD2932 | C24H25N5O4 | 883986-34-3 | Details |
4-Methoxy-1-N-methylbenzene-1,2-diamine | C8H12N2O | 3360-78-9 | Details |
(R)-(3-Aminopyrrolidin-1-yl)(cyclopropyl)methanone hydrochloride | C8H15ClN2O | 1286207-68-8 | Details |
Bradykinin (1-6) acetate salt | C30H45N9O8 | 23815-88-5 | Details |
TLE4 Blocking Peptide | Details |
1H-Undecafluoropentane | C5HF11 | 375-61-1 | Details |
Seco everolimus B | C53H85NO15 | 769905-89-7 | Details |
4-(Hydrazinylmethyl)-N,N-dimethylaniline dihydrochloride | 1909309-06-3 | Details |
Althiomycin | C16H17N5O6S2 | 12656-40-5 | Details |
3-Bromo-1-methanesulfonylpyrrolidine | C5H10BrNO2S | 1536789-90-8 | Details |
1-Ethenyl-2-nitrobenzene | C8H7NO2 | 579-71-5 | Details |
Benzyl N-(4-{[(tert-butoxy)carbonyl]amino}cyclopent-2-en-1-yl)carbamate | C18H24N2O4 | 1935614-32-6 | Details |
5-(3-Cyanophenoxy)pentanoic acid | C12H13NO3 | 1038972-84-7 | Details |
4-[(2,4-Difluorophenyl)methyl]-1H-pyrazole hydrochloride | C10H9ClF2N2 | 2219407-32-4 | Details |
6-Chloro-1-methyl-1H-pyrrolo[2,3-b]pyridine | C8H7ClN2 | 934568-25-9 | Details |
4-(Ethoxymethyl)benzoic acid | C10H12O3 | 146781-28-4 | Details |
5-Bromosalicylhydrazide | C7H7BrN2O2 | 39635-10-4 | Details |
Dihydrorotenone | C23H24O6 | 6659-45-6 | Details |
2-(Butan-2-yl)pyrimidin-5-amine | C8H13N3 | 1247151-56-9 | Details |
3-Ethyl-4-(thiophen-2-yl)-1H-pyrazol-5-amine | C9H11N3S | 955584-79-9 | Details |
SF3B2 antibody | Details |
2-(3-Methylphenyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione | C16H13NO2 | 106110-70-7 | Details |
D-[UL-13C6,15N]Glucosamine HCl | Details |
3-chloro-4-(difluoromethoxy)benzoic acid | C8H5ClF2O3 | 1192829-74-5 | Details |
Ethyl 5-amino-3-methyl-1-benzothiophene-2-carboxylate | C12H13NO2S | 31310-19-7 | Details |
5-(1,3-Benzodioxol-5-yl)-1H-pyrazole-3-carboxylic acid | C11H8N2O4 | 1093642-04-6 | Details |
(1-aza-2-(3-(trifluoromethoxy)phenyl)vinyl)(imino(3-phenylprop-2-enylthio)methyl)amine, hydrobromide | C18H17BrF3N3OS | 1274948-40-1 | Details |
4-[4-(Propan-2-yl)phenoxy]piperidine hydrochloride | C14H22ClNO | 1173079-45-2 | Details |
CDCA7 antibody | Details |
1-(2'-Deoxy-2'-fluoro-b-D-arabinofuranosyl)uracil 5'-triphosphate triethylammonium salt | C9H13FN2O14P3.C6H16N | Details |
4-(1,1-Dioxo-1λ?-thiomorpholin-4-yl)benzene-1-carboximidamide hydrochloride | C11H16ClN3O2S | 1258640-96-8 | Details |
1-phenyl-N-{[3-(trifluoromethyl)phenyl]methyl}cyclopentane-1-carboxamide | C20H20F3NO | 1023876-97-2 | Details |
TSC22D4 antibody | Details |
SEMA4F Blocking Peptide | Details |
2',3'-Dideoxyguanosine-5'-triphosphate lithium salt - 100mM aqueous solution | C10H16N5O12P3 | 68726-28-3 | Details |
CPLX2 antibody | Details |
3,5-Difluorophenylhydrazine hydrochloride | C6H7ClF2N2 | 502496-27-7 | Details |
1-(3-((2-chlorophenyl)amino)-5-methyl-2,4-thiazolyl)ethan-1-one | C12H11ClN2OS | 883265-08-5 | Details |
EGFR antibody (Ser1071) | Details |
Adenosine 2',3'-cyclic monophosphate-5'-monophosphate | Details |
4-Hydroxy-2,9-diazaspiro[5.5]undecan-1-one hydrochloride | 2089277-71-2 | Details |
2-(Piperazin-1-yl)propan-1-ol dihydrochloride | C7H16N2O.2[HCl] | 222297-35-0 | Details |
4-[2-(Dimethylamino)ethoxy]-N-methylaniline | C11H18N2O | 1160623-57-3 | Details |
Methyl 3-(methylsulfonyl)benzoate | C9H10O4S | 22821-69-8 | Details |
2-Phenoxyacetamide | C8H9NO2 | 621-88-5 | Details |
SCGN Blocking Peptide | Details |
N-Ethyl-4-hydroxy-3-nitrobenzene-1-sulfonamide | C8H10N2O5S | 1094326-04-1 | Details |
tert-Butyl 4,4-dicyanopiperidine-1-carboxylate | C12H17N3O2 | 1267759-28-3 | Details |
IAPP antibody | Details |
Product Total: Product Page: | ||||
30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 |